MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
-$7,966,538
Interest income
$125,445
Operating loss
-$8,091,983
Total operating
expenses
$8,091,983
General and
administrative
$6,257,477
Research and development
$1,834,506
Back
Back
Income Statement
source: myfinsight.com
Acurx Pharmaceuticals, Inc. (ACXP)
Acurx Pharmaceuticals, Inc. (ACXP)